Armata Pharmaceuticals Inc (NYSEAMERICAN:ARMP), the biotechnology company, is involved in the development of pathogen-specific bacteriophage therapeutics, which are meant for targeting antibiotic-resistant and bacterial infections which are difficult to treat. The stock has been in the middle of a strong rally in recent times and it continued on Wednesday as the stock soared by 31%. …
ARMP
Armata Pharmaceuticals Inc (ARMP) Stock Extends Rally: Is It Sustainable?
Armata Pharmaceuticals Inc (NYSEAMERICAN:ARMP) The clinical stage biotech company is involved in the development bacteriophage therapeutics which are pathogen specific for treating difficult to treat and antibiotic resistant bacterial infections. The company accomplishes that through the use of its proprietary bacteriophage-based technology. The company is involved in the development and advancement of a wide pipeline …
Continue reading “Armata Pharmaceuticals Inc (ARMP) Stock Extends Rally: Is It Sustainable?”